We are monitoring the impact of COVID-19 on APAC Transfection Reagents And Equipment Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Transfection Reagents And Equipment Market Research Report - Segmented By Product, Method, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts 2022 to 2027

Published: January, 2022
ID: 3089
Pages: 178

Asia Pacific Transfection Reagents and Equipment Market Size & Growth (2022 to 2027):

As per the research report, the size of the Asia-Pacific Transfection Reagents and Equipment market size was valued at USD 223.22 million in 2022. It is expected to grow at a CAGR of 8% to reach USD 327.98 million by 2027 during the forecast period 2022 to 2027.

Reagents and instruments are divided into two categories in the Asia-Pacific transfection reagents and equipment market. One of the most important factors is that the transfection reagents and equipment market has evolved through time to fulfil the needs of researchers and biotechnology and pharmaceutical firms.

Market developments have resulted in the development of more efficient high-throughput large-scale transfection devices and reagents. Advanced methods enable efficient quantitative and qualitative transfection in a wide range of cells, including those that are difficult to transfect.

Another important feature is the expertise in consulting projects and market research in high-growth areas, cutting-edge technologies, and novel applications.

The technology in Transfection reagents and equipment aids cells in cancer cell mutation, protein metabolism by influencing nuclear genes, and gene therapy control. Transfection is a crucial tool in gene function and gene expression regulation research.

Basic cellular research, drug discovery, and target validation all benefit from it. The market for transfection reagents and equipment is fueled by protein production, an ageing population, and an increase in cancer prevalence. The market for transfection reagents and equipment has been boosted by a number of government initiatives.

However, the high cost of transfection reagents and equipment, as well as risk issues during reagent insertion and the cytotoxic effect associated with transfection technology, are limiting the market for transfection reagents and equipment.

This research report on the APAC Transfection Reagents and Equipment Market has been segmented and sub-segmented into the following categories:

By Product:

  • Reagents
  • Instruments     

By Method:

  • Biochemical
  • Calcium Phosphate
  • Physical
  • Viral  

By Application:

  • Biomedical Research
  • Protein Production
  • Therapeutic Delivery           

By End User:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies  

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is one of the fastest growing regions in terms of transfection reagents and equipment in the world due to rising occurrence of various malignancies such as cervical cancer, breast cancer, colon cancer, and prostate cancer.

Furthermore, increased demand for proteomics and genomics technologies, as well as proactive government activities aimed at preventing disease, have aided the growth of the transfection reagents and equipment market in this area. The need for transfection reagents and equipment is influenced by the developing trend of targeted drug delivery, nanomedicine in diagnostics, clinical trials, and drug development investigations.          

In the transfection reagents and equipment industry, Asia-Pacific is still considered an emerging market in its early stages. Outsourcing of clinical trials to Asian nations such as India, Japan, and China by the bulk of drug research corporations is one of the primary regional drivers impacting the rise of transfection reagent and equipment.

Furthermore, the advancement of in transfection technology, the demand for protein therapies, the growth of healthcare infrastructure in growing countries such as India and China, and rising demand from application markets are also factors to consider. Because of the expanding medical infrastructure, high disposable income, and rising prevalence, there is a huge potential for expansion.

Reagents of this type can be employed in a variety of ways, including chemical, physical, and biological methods. Technological developments in transfection, an increase in R&D spending and research activities by biotech companies, and a rise in demand for synthetic genes are all important regional factors that are stifling industry expansion.

KEY MARKET PLAYERS

The Top companies leading in the APAC Transfection Reagents and Equipment Market profiled in the report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).,

1.Introduction          

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

                                5.1.1 Reagents                 

                                5.1.2 Instruments                           

                                5.1.3  Y-o-Y Growth Analysis, By Product                              

                                5.1.4  Market Attractiveness Analysis, By Product                            

                                5.1.5  Market Share Analysis, By Product                              

                5.2 Method                                       

                                5.2.1 Biochemical                            

                                5.2.2 Calcium Phosphate                              

        5.2.2.1 Lipofection          

                        5.2.2.1.1 Advantages

                        5.2.2.1.2 Disadvantages

        5.2.2.2 Calcium Phosphate          

                        5.2.2.2.1 Advantages

                        5.2.2.2.2 Disadvantages

        5.2.2.3 DEAE-dextran    

                        5.2.2.3.1 Advantages

                        5.2.2.3.2 Disadvantages

        5.2.2.4 Dendrimers         

                        5.2.2.4.1 Advantages

                        5.2.2.5.1 Disadvantages

                                5.2.3 Physical                    

        5.2.3.1 Electroporation 

                        5.2.3.1.1 Advantages

                        5.2.3.1.2 Disadvantages

        5.2.3.2 Nucleofection    

                        5.2.3.2.1 Advantages

                        5.2.3.2.2 Disadvantages

        5.2.3.3.Others  

                        5.2.3.3.1 Sonoporation

                        5.2.3.3.2 Genegun

                        5.2.3.3.3 Magnetofection

                        5.2.3.3.4 Optoinjection

                                5.2.4 Viral                           

        5.2.4.1 Adenoviruses     

        5.2.4.2 Retroviruses       

        5.2.4.3 Adenoassociated Viruses (AAV)

                                5.2.5 Y-o-Y Growth Analysis, By Method                               

                                5.2.6 Market Attractiveness Analysis, By Method                             

                                5.2.7 Market Share Analysis, By Method                              

                5.3 Application                                 

                                5.3.1 Biomedical Research                           

        5.3.1.1 Gene Expression Studies              

        5.3.1.2 Cancer Research               

        5.3.1.3 Transgenic Model             

                                5.3.2 Protein Production                              

                                5.3.3 Therapeutic Delivery                          

                                5.3.4 Y-o-Y Growth Analysis, By Application                         

                                5.3.5  Market Attractiveness Analysis, By Application                      

                                5.3.6  Market Share Analysis, By Application                       

                5.4 End User                                      

                                5.4.1 Academic & Research Institutes                    

                                5.4.2 Pharmaceutical & Biotechnology Companies                           

                                5.4.3 Y-o-Y Growth Analysis, By End User                             

                                5.4.4  Market Attractiveness Analysis, By End User                          

                                5.4.5  Market Share Analysis, By End User                            

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

        6.1.3.1 By Geographical Area     

        6.1.3.2 By Product           

        6.1.3.3 By Method          

        6.1.3.4 By Application    

        6.1.3.5 By End User        

                                6.1.4  Market Attractiveness Analysis                     

        6.1.4.1 By Geographical Area     

        6.1.4.2 By Product           

        6.1.4.3 By Method          

        6.1.4.4 By Application    

        6.1.4.5 By End User        

                                6.1.5  Market Share Analysis                      

        6.1.5.1 By Geographical Area     

        6.1.5.2 By Product           

        6.1.5.3 By Method          

        6.1.5.4 By Application    

        6.1.5.5 By End User        

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia                                      

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                 

                8.1 Thermo Fisher Scientific Inc. (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Promega Corporation (U.S.)                                

                8.3 Hoffmann-La Roche Ltd. (Switzerland)   

                8.4 QIAGEN N.V. (Netherlands)                                

                8.5 Polyplus-transfection SA (France)                                    

                8.6 Bio-Rad Laboratories (U.S.)                                 

                8.7 Lonza Group (Switzerland)                                  

                8.8 Sigma-Aldrich Corporation (U.S.)                                      

                8.9 Mirus Bio LLC (U.S.)                                 

                8.10 MaxCyte Inc. (U.S.)      

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                                

                b) List of Figures      

  1. Asia-Pacific Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  2. Asia-Pacific Reagents Market By Region, From 2022 - 2027 ( USD Million )
  3. Asia-Pacific Instruments Market By Region, From 2022 - 2027 ( USD Million )
  4. Asia-Pacific Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  5. Asia-Pacific Biochemical Market By Region, From 2022 - 2027 ( USD Million )
  6. Asia-Pacific Calcium Phosphate Market By Region, From 2022 - 2027 ( USD Million )
  7. Asia-Pacific Lipofection Market By Region, From 2022 - 2027 ( USD Million )
  8. Asia-Pacific DEAE-dextran Market By Region, From 2022 - 2027 ( USD Million )
  9. Asia-Pacific Dendrimers Market By Region, From 2022 - 2027 ( USD Million )
  10. Asia-Pacific Physical Market By Region, From 2022 - 2027 ( USD Million )
  11. Asia-Pacific Electroporation Market By Region, From 2022 - 2027 ( USD Million )
  12. Asia-Pacific Nucleofection Market By Region, From 2022 - 2027 ( USD Million )
  13. Asia-Pacific Others Market By Region, From 2022 - 2027 ( USD Million )
  14. Asia-Pacific Viral Market By Region, From 2022 - 2027 ( USD Million )
  15. Asia-Pacific Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  16. Asia-Pacific Biomedical Research Market By Region, From 2022 - 2027 ( USD Million )
  17. Asia-Pacific Gene Expression Studies Market By Region, From 2022 - 2027 ( USD Million )
  18. Asia-Pacific Cancer Research Market By Region, From 2022 - 2027 ( USD Million )
  19. Asia-Pacific Transgenic Model Market By Region, From 2022 - 2027 ( USD Million )
  20. Asia-Pacific Protein Production Market By Region, From 2022 - 2027 ( USD Million )
  21. Asia-Pacific Therapeutic Delivery Market By Region, From 2022 - 2027 ( USD Million )
  22. Asia-Pacific Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )
  23. Asia-Pacific Academic & Research Institutes Market By Region, From 2022 - 2027 ( USD Million )
  24. Asia-Pacific Pharmaceutical & Biotechnology Companies Market By Region, From 2022 - 2027 ( USD Million )
  25. Japan Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  26. Japan Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  27. Japan Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  28. Japan Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )
  29. China Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  30. China Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  31. China Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  32. China Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )
  33. India Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  34. India Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  35. India Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  36. India Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )
  37. Australia Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  38. Australia Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  39. Australia Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  40. Australia Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )
  41. South Korea Transfection Reagents and Equipment Market By Product, From 2022 - 2027 ( USD Million )
  42. South Korea Transfection Reagents and Equipment Market By Method, From 2022 - 2027 ( USD Million )
  43. South Korea Transfection Reagents and Equipment Market By Application, From 2022 - 2027 ( USD Million )
  44. South Korea Transfection Reagents and Equipment Market By End User, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample